• @finitebanjo
    link
    321 day ago

    It’s a pharmaceutical company. They’re no saints, but it’s disingenuous to compare them to people who take money and provide nothing but a rubber stamp.

    • @[email protected]
      link
      fedilink
      77 hours ago

      people who take money and provide nothing but a rubber stamp

      They don’t even do that. Their incentive is to deny coverage. They’re not healthcare insurance companies, they’re healthcare rationing companies. And we pay them.

    • @[email protected]
      link
      fedilink
      26 hours ago

      The providers (hospitals, clinics, labs, doctor practices), insurers/payers (whether for profit like United, nonprofit like most Blue Cross Blue Shields, or government like Medicare), and pharmaceutical/medical device companies fight each other the whole time to make the most money off of the patients/beneficiaries/taxpayers. Big Pharma runs up prices and persuades doctors to prescribe their treatments, while doctors themselves have a profit motive in running up unnecessary treatments, all while insurers try not to pay for stuff, necessary or not.

      It’s a broken system, but it’s also worth pointing out that the scammers in each camp hate the other camps just as much as the public does. There are hospital execs and pharma execs basically cheering on the anger at insurers, who will turn around and rip off the same victims in a different way.

      • @finitebanjo
        link
        15 hours ago

        Yes and thats because the solution isnt to put different people in charge of the companies. The solution is to Regulate.

        The corruption is because we voters built the system to enable corruption. None of us are better than the executives or vice versa

    • @[email protected]
      link
      fedilink
      2519 hours ago

      Did everyone forget about scumbag Martin Shkreli who raised medication prices for no reason other than he wanted more money?

      “In September 2015, Shkreli was widely criticized when Turing obtained the manufacturing license for the antiparasitic drug Daraprim and raised its price to insurance companies from $13.50 to $750.00 (USD) per pill.”

      • @finitebanjo
        link
        1
        edit-2
        5 hours ago

        Martin worked at Retrophin and Turing Pharmaceuticals but mostly he was a hedge fund manager.

        Got nothing to do with Parker or Mangione.